{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000583","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.396686+00:00","generated_at":"2026-05-27T05:12:44.115132+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CNBX Pharmaceuticals enters convertible note with $55K initial, up to $850K, 35% discount conversion","bullets":["Issue Date Jan 23, 2025; maturity Oct 30, 2025; 10% interest, 9% OID, default interest 22%.","Conversion price at 65% of market price (35% discount), exercisable from day 180.","Company may prepay at 110%-130% of face during first 180 days; later subject to holder agreement.","Company must register all shares; holder prohibited from short-selling during term.","Institutional investor 1800 Diagonal Lending LLC provided $55,000, with potential up to $850,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000583","json":"https://secwatch.observer/filing/0001683168-25-000583.json","markdown":"https://secwatch.observer/filing/0001683168-25-000583.md","text":"https://secwatch.observer/filing/0001683168-25-000583.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/0001683168-25-000583-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/cnbx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:12:44.115132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}